Personally I think this is a solid choice of investment by Purpose Ventures and i will share you my thoughts on this. A growing trend in healthcare will be; -real world evidence based research/drug development -potentially to utilise and leverage off ai-driven to further boost data gathered from real world evidence leading to quicker lead time for drug development or research -bespoke, this is the next big trend in advancement of medical treatment will be a tailored to each individual We can see even on outside of the private equity space, companies like Emyria (ASX:EMD) is backed by Tenmile on solely those trends alone. I never knew there is many australian companies who are in the forefront of bio-tech and lets not forget, the benefits of RnD too, i think is somewhere on 43.5% which is relatively high to foster innovation. Nevertheless great and solid choice for the long run Derek Gerrard Kylie Gerrard seeing some 🔥 action for the fund.
We’re excited to announce our fourth investment in WA biotech company Gene S Pty Ltd We’re backing founders Svetlana Baltic Suzanna Lindsey-Temple and the team to build the next generation of precision medicine. Through a DNA test we can sure patients receive the right medication and the right dose at the right time. We have lots of verticals but starting with mental health where first drug use is wrong 50% of the time. Better health outcomes and more cost savings. Dr Marcus Tan Derek Gerrard Kylie Gerrard Kirsty Packer Joshua Skalnik Lachlan Scotford Brodie McCulloch Nicole Lockwood Department of Jobs, Tourism, Science and Innovation CERI - Centre for Entrepreneurial Research and Innovation
